GlassScriptPhysician profile
Steven A Schiffenhaus
NPI 1124476353
$43,569.36
in general payments reported to CMS, 2019-2025
13 companies · $9,321 in 2025
The $9,321 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,242 · 2020: $7,186 · 2021: $3,500 · 2022: $13K · 2023: $6,755 · 2024: $299 · 2025: $9,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $11K · Food and Beverage: $3,301 · Travel and Lodging: $1,786 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $11,000.00 |
| Food and Beverage | $3,300.88 |
| Travel and Lodging | $1,786.28 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuraray America INC. | $20,694.25 | 2020-2025 | |
| Sprintray INC | $8,761.94 | 2024-2025 | Pro 2 3d Printer |
| Carl Zeiss Meditec USA, INC. | $2,783.20 | 2022 | |
| Truabutment INC. | $2,715.00 | 2023 | |
| Gc America INC. | $2,260.28 | 2019-2025 | G-Bond, G-Aenial, G-Aenial |
| Dentsply LLC | $1,841.95 | 2019-2021 | |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Dentsply Sirona INC | $1,301.93 | 2019-2023 | |
| Ivoclar Vivadent, INC. | $972.18 | 2023 | |
| Hu-Friedy Mfg. Co., LLC | $374.23 | 2021-2022 | |
| Planmeca USA, INC. | $283.00 | 2021 | |
| Straumann USA LLC | $55.00 | 2020-2021 | |
| Nobel Biocare USA | $26.40 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schiffenhaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.